)
Visual
test
Cabaletta Bio
Cabaletta Bio (CABA) investor relations material
Cabaletta Bio Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary23 Mar, 2026
Executive summary
Advanced two innovations: rese-cel with no preconditioning and automated manufacturing using Cellares Cell Shuttle, with clinical data expected in 1H26 and durability data throughout 2026.
Registrational cohort for myositis enrolling, targeting a 2027 BLA submission; pivotal trial designs for SLE and LN announced, with SSc design update expected in 1H26.
RESET clinical program spans multiple autoimmune diseases in rheumatology, neurology, and dermatology.
Financial highlights
Research and development expenses rose to $36.2M for Q4 2025 and $142.7M for FY 2025, up from $25.5M and $97.2M in 2024.
General and administrative expenses were $6.4M for Q4 2025 and $29.6M for FY 2025, compared to $8.3M and $27.9M in 2024.
Net loss for Q4 2025 was $41.9M and $167.9M for FY 2025, compared to $32.6M and $115.9M in 2024.
Cash, cash equivalents, and short-term investments totaled $133.6M as of December 31, 2025, with an additional $30M raised in Q1 2026.
Cash position expected to fund operations into Q4 2026.
Outlook and guidance
Initial RESET-SLE data (no preconditioning) expected in 1H26, with durability data from RESET-SLE and RESET-PV throughout 2026.
Complete Phase 1/2 data from RESET-SSc, RESET-SLE, and RESET-MG trials to be presented in 1H26.
Update on registrational designs for RESET-SSC in 1H26 and RESET-MG in mid-2026.
BLA submission for rese-cel in myositis planned for 2027.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cabaletta Bio
- Rese-cel delivers transformative, outpatient-ready CAR T therapy for autoimmune diseases.CABA
Corporate presentation23 Mar 2026 - Automated CAR T manufacturing and no preconditioning may revolutionize autoimmune therapy.CABATD Cowen 46th Annual Health Care Conference3 Mar 2026
- Automated manufacturing and outpatient CAR-T therapy drive a scalable, high-margin business model.CABAGuggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026
- Pivotal CD19-CAR T trials show strong efficacy, safety, and outpatient potential in autoimmunity.CABACorporate presentation12 Feb 2026
- CABA-201 shows strong safety, immune reset, and early efficacy in autoimmune disease trials.CABAStudy Update3 Feb 2026
- Broad autoimmune cell therapy trials advance with strong enrollment and key data updates expected soon.CABA2024 Wells Fargo Healthcare Conference22 Jan 2026
- CABA-201 advances in autoimmune CAR-T with rapid enrollment, robust data, and manufacturing innovation.CABAMorgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026
- Accelerating enrollment and innovative trial design position the program for transformative impact.CABAH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Accelerated enrollment and site expansion position CABA-201 as a leader in autoimmune CAR T trials.CABA2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
Next Cabaletta Bio earnings date
Q1 202614 May, 2026
Cabaletta Bio
Next Cabaletta Bio earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage